0

Your Cart is Empty

Whilst working to raise funds for trials, we have helped over 100,000 people  to obtain LDN from a General Practitioner or Consultant, either through the National Health Service or by private prescription.  We are proud to have helped people not just in the UK but in countries throughout Europe, as well as the USA, Canada, West Indies, Australia, New Zealand, and beyond. On this website and from our downloadable newsletters, you will be able to read the stories of some of these people.

We have helped many people with MS, Crohn's, IBS, ME and Cancer to name a few conditions LDN can treat. The use of LDN is spreading.

By raising awareness of LDN and funding clinical trials that will be published for the benefit of the public, we hope to achieve our ultimate goal for everyone to be prescribed LDN on the NHS and around the world, for all conditions where LDN could be of benefit. The LDN Research Trust is a non-profit-making Registered Charity, and everyone is a volunteer. Only expenses for the running of the Charity will be taken, and these will be at cost.
To help us continue our work to bring relief to all people with Multiple Sclerosis and other conditions, we would appreciate help with fund raising, either in cash or in kind. You can be sure that all contributions are greatly appreciated, however small.

Get in touch

SIGN UP FOR FURTHER INFORMATION

* indicates required
Which Mailing List Would you like to join? *

LDN Research Trust will use the information you provide on this form to enable us to email you to provide, newsletters, events, announcements and marketing materials. Please tick the email boxes below.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at contact@ldnresearchtrust.org. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.